Ballast, Inc. Abbott Laboratories Transaction History

Ballast, Inc.

$353 Million
Q1 2025

A detailed history of Ballast, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ballast, Inc. holds 2,693 shares of ABT stock, worth $361,212. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,693

Previous 2,606 3.34%

Holding current value

$361,212

Previous $294,000 21.43%

% of portfolio

0.1%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$111.1 - $140.22 $9,665 - $12,199	87 Added 3.34%	2,693 $357,000
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $67,447 - $79,619	-674 Reduced 20.55%	2,606 $297,000
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $63,661 - $71,062	-632 Reduced 16.16%	3,280 $340,000
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $2,435 - $2,980	-27 Reduced 0.69%	3,912 $430,000
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $2,579 - $3,094	27 Added 0.69%	3,939 $381,000
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $16,255 - $19,069	-171 Reduced 4.19%	3,912 $0
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $24,190 - $28,007	-250 Reduced 5.77%	4,083 $395,000
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $39,907 - $48,664	-350 Reduced 7.47%	4,333 $512,000
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $289,056 - $353,932	2,502 Added 114.72%	4,683 $659,000
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $230,727 - $271,599	2,181 New	2,181 $252,000
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $237,380 - $279,669	-2,181 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $50,400 - $54,921	-480 Reduced 18.04%	2,181 $238,000
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $243,854 - $296,142	2,661 New	2,661 $289,000

Others Institutions Holding ABT

# of Institutions

3,544

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $235B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ballast, Inc. with notifications on news.

Account